Kenji Osumi

Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities

Masaki Kurogochi, Masako Mori, Kenji Osumi et al. · PLoS ONE · 2015 · 94 citations · Full text

Glycoengineered Monoclonal Antibodies, Glycobiology, Immunology +28

Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies

Michihiko Aoyama, Noritaka Hashii, Wataru Tsukimura et al. · mAbs · 2019 · 67 citations · Full text

Synthesis of mono-glucose-branched cyclodextrins with a high inclusion ability for doxorubicin and their efficient glycosylation using Mucor hiemalis endo-β-N-acetylglucosaminidase

Takashi Yamanoi, Naomichi Yoshida, Yoshiki Oda et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 41 citations

Medicinal Chemistry, Biosynthesis, Bioorganic Chemistry +11

High efficiency of transferring a native sugar chain from a glycopeptide by a microbial endoglycosidase in organic solvents

Eri Akaike, Maki Tsutsumida, Kenji Osumi et al. · Carbohydrate Research · 2004 · 40 citations

Biosynthesis, Engineering, Organic Solvents +13

Total Synthesis of (−)-trans-kumausyne

Kenji Osumi, Hideyuki Sugimura · Tetrahedron Letters · 1995 · 40 citations

Engineering, Total Synthesis, Organic Chemistry +3